Drug Shortage Report for THALLOUS CHLORIDE TI-201 INJECTION

Last updated on 2025-10-06 History

Report ID	171882
Drug Identification Number	Not Applicable/non applicable
Brand name	THALLOUS CHLORIDE TI-201 INJECTION
Common or Proper name	thallous chloride Tl201 injection
Company Name	CURIUM CANADA INC
Market Status	DORMANT
Active Ingredient(s)	THALLIUM CHLORIDE
Strength(s)	37MBq
Dosage form(s)	SOLUTION
Route of administration	INTRAVENOUS INTRAVENOUS
Packaging size	2.8 to 9.9 mCi
ATC code	V09GX
ATC description
Reason for shortage	Other (Please describe in comments)
Anticipated start date	2022-10-07
Actual start date	2022-10-07
Estimated end date	Unknown
Actual end date
Shortage status	Actual shortage
Updated date	2025-10-06
Company comments	Following the discontinuation of Lantheus product, Curium is unable to cover lantheus market. Please also note that as of 28OCT20222, Curium will require maintenance on one of its cyclotron resulting in suspension of production for Curium Thallous Chloride injection during that period. The product was rendered dormant as of 18JUN2025
Health Canada comments
Tier 3 Status	No
Contact Address	2572 BOUL. DANIEL-JOHNSON LAVAL, QUEBEC CANADA H7T 2R3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Showing 1 to 20 of 40